Join
Live feed
·
PRReleasevia Quantisnow
Edesa Biotech Inc. logo

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference

ByQuantisnow·Wall Street's wire, on your screen.
EDSA· Edesa Biotech Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EDSA (Edesa Biotech Inc.) and more on Quantisnow.